$3.25-0.77 (-19.15%)
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers.
Shuttle Pharmaceuticals Holdings, Inc. in the Healthcare sector is trading at $3.25 with a market capitalization of $3M. The stock is currently near its 52-week low of $2.90, remaining 81.0% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 25/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | β | β | β | β | β |
| Operating Income | -$2.22Mβ | -$2.79Mβ | -$2.27Mβ | -$3.91Mβ | -$2.95M |
| Net Income | -$2.15Mβ | -$2.61Mβ | -$2.35Mβ | -$3.71Mβ | -$3.05M |
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug de...
AI infrastructure plan, SpaceX exposure, and Nasdaq compliance update boosted investor sentiment.
Shuttle Pharmaceuticals Holdings (NASDAQ: $SHPH) said it has signed a definitive merger agreement to acquire United...
This pharma name is betting AI can shave time, cost, and guesswork out of cancer drug development [Sponsored Post]